跳至主要内容
临床试验/NCT02406456
NCT02406456已完成不适用

Real-time fMRI Neurofeedback as a Treatment Tool for Alcohol Dependence - Protocol Optimisation Phase

Cardiff University2 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2015年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
15
试验地点
2
主要终点
Neurofeedback success (brain activation difference during neurofeedback and baseline blocks)

研究概览

简要总结

Participants will undergo a single session of functional magnetic resonance imaging (fMRI)-based neurofeedback (approximately 1 hour). The investigators will assess their ability to regulate motivational networks of the brain during the exposure to alcohol cues and evaluate immediate effects on craving and cognitive bias for alcohol by administering a questionnaire and a Stroop task before and after the session.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • History of alcohol use disorder or current alcohol consumption above 21 units (1 unit = 8g) of alcohol per week (male participants) or above 14 units of alcohol per week (female participants)

排除标准

  • MRI safety exclusion criteria

结局指标

主要结局

Neurofeedback success (brain activation difference during neurofeedback and baseline blocks)

时间窗: 1 day

This measure will be based on the analysis of participants' fMRI (functional magnetic resonance imaging) data, reflecting brain activation, during exposure to alcohol cues. Neurofeedback success will be defined as significant difference between activation levels (expressed as beta weights of a linear regression model) during the regulation periods compared to baseline. The significance will be determined by a t-test.

次要结局

  • Alcohol Stroop task as a measure of cognitive bias(1 day)
  • Drinking Urges Questionnaire as a measure of alcohol craving(1 day)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

David Linden

Professor of Translational Neuroscience

Cardiff University

研究点 (2)

Loading locations...

相似试验

Optimisation of Functional MRI-based Neurofeedback... | 临床试验